Parallax Volatility Advisers
LABU icon

Parallax Volatility Advisers’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Parallax Volatility Advisers’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-164
Closed -$181K – 3242
2021
Q3 		$181K Buy
+164
New +$202K ﹤0.01% 2530

Other funds holding LABU

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GTS Securities
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Ethos Financial Group
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Parallax Volatility Advisers's LABU Position: Q4 2021 in Review

Parallax Volatility Advisers sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2021, closing a stake of 164 shares — an estimated $181K sold.

Parallax Volatility Advisers first reported a position in LABU in Q3 2021 and held it in 1 quarter. The position peaked at $181K in Q3 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q4 2021.

  • Parallax Volatility Advisers reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 164 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2021, an estimated $181K.
  • Parallax Volatility Advisers first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2021 and held it in 1 quarter.
  • Parallax Volatility Advisers's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $181K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2021.

Based on Parallax Volatility Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.